Medicines for the People: what will the next decade look like?

Non-commercial pharmaceutical R&D: What do PDPs suggest about costs and efficiency?

WTO A4T Session 38 | Trade Facilitation: Critical for COVID-19 Recovery

WTO A4T Session 35 | Financial response to pandemic crises affecting LDCs: The contribution of Aid for Trade

WTO A4T Session 20 | Investing in Safe Trade Systems to Protect Health and Market Access

WTO A4T Session 12 | COVID-related MSME Aid for Trade

WTO A4T Session 8 | High Level Plenary Session

WTO A4T Session 6 | COVID-19 and Global Value Chains – an Opportunity for Diversification?

WTO A4T Session 4 | Developing Production and Supply Capacities of Medical Equipment in LDCs

Water & sanitation in the city: good & bad experiences, what are the lessons?